Business UpdateJun 22, 2026, 04:16 PM
Imunon CEO to Present at Life Sciences Investor Forum on June 25
AI Summary
Imunon, Inc. announced that its President and CEO, Stacy Lindborg, Ph.D., will present at the Life Sciences Investor Forum on Thursday, June 25, 2026, at 12:00 p.m. ET. The live, interactive online event will allow investors to ask questions in real-time, with one-on-one meetings also available. An archived webcast will be posted on the company's website. Imunon is a clinical-stage biotechnology company with a lead Phase 3 program, IMNN-001, for advanced ovarian cancer, and has completed dosing for its COVID-19 booster vaccine, IMNN-101.
Key Highlights
- Imunon CEO Stacy Lindborg to present at the Life Sciences Investor Forum.
- Presentation scheduled for Thursday, June 25, 2026, at 12:00 p.m. ET.
- The event will be a live, interactive online session for investors.
- One-on-one meetings with company management are available for scheduling.
- An archived webcast will be accessible on the Imunon website after the event.
- Company is in Phase 3 development with IMNN-001 for advanced ovarian cancer.
- Completed dosing for first-in-human study of COVID-19 booster vaccine IMNN-101.
- Imunon is a clinical-stage biotechnology company focused on innovative treatments.
Price Impact
More from IMNN